ABL1 and acute myeloid leukemia: Aberrant chromosomal translocation BCR–ABL kinase and activation of FMS-like tyrosine kinase 3 (FLT3) receptor tyrosine can induce STAT 5 activation in CML and Acute myeloid leukemia (AML), respectively.